• $29.0M
    Market Cap
  • 460.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
0
N/A
0
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
56,393
+59.53%
35,350
0.00%
35,350
N/A
Total Operating Expenses
238,364
-6.86%
255,926
-0.77%
257,911
N/A
Operating Profit
-238,364
-6.86%
-255,926
-16.23%
-305,511
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-66,473
+13.90%
-58,359
+35.86%
-42,955
N/A
Interest Income and Expense and Net
-66,473
+13.90%
-58,359
+35.86%
-42,955
N/A
Total Nonoperating Income and Expense
66,473
+209.85%
-60,511
-240.87%
42,955
N/A
Income before Taxes
-323,952
+2.37%
-316,437
+3.58%
-305,511
N/A
Income Taxes
N/A
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-323,952
+2.37%
-316,437
+3.58%
-305,511
N/A
Net Income from Continuing Operations Applicable to Common
-323,952
+2.37%
-316,437
+22.69%
-257,911
N/A
Basic EPS and Net Income
-0.01
-50.00%
-0.02
0.00%
-0.02
N/A
Diluted EPS and Net Income
-0.01
-50.00%
-0.02
0.00%
-0.02
N/A
Basic Weighted Average Shares
20.5M
+0.70%
20.4M
+0.76%
20.2M
N/A
Diluted Weighted Average Shares
20.5M
+0.70%
20.4M
+0.76%
20.2M
N/A
Balance Sheet
Cash and Cash Equivalents
12,258
-77.85%
55,351
+32.51%
41,770
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
12,258
-77.85%
55,351
+32.51%
41,770
N/A
Total Current Assets
24,116
-58.47%
58,062
+39.00%
41,770
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
77,386
-14.34%
90,345
-28.12%
125,695
N/A
Total Long-Term Assets
77,386
-14.34%
90,345
-28.12%
125,695
N/A
Total Assets
101,502
-31.61%
148,407
-11.38%
167,465
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
46,545
-88.03%
388,806
-2.51%
398,806
N/A
Total Current Liabilities
561,785
+15.91%
484,672
+3.15%
469,893
N/A
Total Long-Term Debt
50,000
-50.00%
100,000
+100.00%
50,000
N/A
Total Long-Term Liabilities
50,000
-50.00%
100,000
+100.00%
50,000
N/A
Total Liabilities
611,785
+4.64%
584,672
+12.46%
519,893
N/A
Retained Earnings
-1.5M
+28.40%
-1.1M
+38.39%
-824,277
N/A
Total Stockholders Equity
-510,283
+16.97%
-436,265
+23.79%
-352,428
N/A
Total Shares Outstanding
20.6M
+0.76%
20.5M
+0.81%
20.3M
N/A
Cash Flow
Cash from Operating Activities
-219,659
+24.44%
-176,519
-5.95%
-187,687
N/A
Capital Expenditures
43,435
N/A
N/A
N/A
0
N/A
Cash from Investing Activities
-43,435
N/A
N/A
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
220,000
+15.73%
190,100
-15.23%
224,250
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-259.26%
+29.40%
-200.36%
+9.43%
-183.10%
N/A
Return on Equity
68.45%
-14.70%
80.24%
-16.76%
96.40%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.04
-64.19%
0.12
+34.76%
0.09
N/A
Cash Ratio
0.02
-80.91%
0.11
+28.46%
0.09
N/A
Debt-to-Equity Ratio
-0.19
-83.11%
-1.12
-12.02%
-1.27
N/A
Debt-to-Assets Ratio
0.95
-71.12%
3.29
+22.90%
2.68
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow